EGFR and adenocarcinoma: Non-small-cell lung cancer (NSCLC) is the most common type with 40% of the patients presenting with adenocarcinoma [2] Approximately 10–20% of Caucasian patients with non-resectable lung adenocarcinoma have somatic mutations of the epidermal growth factor receptor (EGFR) gene.